All lobbying filings

WILLIAMS AND JENSEN, PLLC

Lobbying for NOVO NORDISK INC. · Pharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Jul 21, 2025

Official filing document

Bills named in this filing 1

HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 5

Health Issues

Medication affordability and access; general diabetes prevention. Pharmacy benefit manager reform proposals. H.R. 1; issues related to biopharmaceutical drug pricing, particularly related to MFN. 340B.

Budget/Appropriations

Support for obesity drug coverage and access.

Medicare/Medicaid

Treat and Reduce Obesity Act; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169) implementation. Pharmacy benefit manager reform proposals. H.R. 1, One Big Beautiful Bill Act, issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.

Taxation/Internal Revenue Code

Issues related to corporate tax and international tax including related domestic and international tax issues considered for reconciliation legislation and H.R. 1, One Big Beautiful Bill Act".

General issues related to patent protections.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.